NCT05251831View on ClinicalTrials.gov

Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

February 1, 2021

Study Completion Date

March 30, 2021

Conditions
Alopecia Areata
Interventions
DRUG

Intradermal injection

Platelet-rich plasma (PRP) therapy uses injections of a concentration of a patient's own platelets.

Trial Locations (1)

11311

Al-Azhar University in Cairo, Cairo

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT05251831 - Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP | Biotech Hunter | Biotech Hunter